Quick Overview: Educational Sessions Triple Negative Breast Cancer: Critical Update on Biology and Management SPOTLIGHT POSTER DISCUSSIONS Spotlight Poster Discussion 6 - Spotlight Poster Discussion 1- Endocrine Resistance: Novel mechanisms and emerging new therapies Transcriptional ...

Sabcs 2021 Genomic And Transcriptomic - Detailed Overview & Context

Educational Sessions Triple Negative Breast Cancer: Critical Update on Biology and Management SPOTLIGHT POSTER DISCUSSIONS Spotlight Poster Discussion 6 - Spotlight Poster Discussion 1- Endocrine Resistance: Novel mechanisms and emerging new therapies Transcriptional ... Spotlight Poster Discussion 3 - Targets in Triple Negative Breast Cancer Combined inhibition of CDK4/6 and AKT (LAR subtype) ... The session took place at 4 p.m. on Tuesday, Dec. 10, 2024. It was an Educational Session YOUTUBE CHANNELS 0:00 ... Rani Bansal, MD, Duke Cancer Center, Durham, NC, discusses an investigation into the

POSTER SESSION 4 Spotlight Poster Discussion 10 - Novel immunotherapy approaches David B. Page, MD Providence Cancer ... Breast Cancer experts Dr. Virginia Kaklamani and Dr. Komal Jhaveri discuss the recent announcement of Phase 3 results of the ... MINI SYMPOSIA The Evolution of Local Therapy in the EDUCATIONAL SESSIONS Targeting the “Un-druggable” RNA metabolism and splicing Trey Westbrook, PhD Baylor College of ... EDUCATIONAL SESSIONS Anti-cancer Immune Response Optimizing immunotherapy efficacy in the clinic through biomarkers: Advances ... Dr. Norah Lynn Henry, MD, PhD moderates a session on exploring new

Photo Gallery

SABCS 2021: "Genomic and transcriptomic landscape of TNBC"
SABCS 2021: Comprehensive genomic profiling of patients with breast cancer ...
SABCS 2021: The Breast PreCancer Atlas DCIS genomic signatures define biology ...
SABCS 2021: Genomic and genetic analysis on metastases
SABCS 2021: "Genomic and genetic analysis on metastases"
SABCS 2021: "Transcriptional reprogramming, ESR1 mutations, and novel targets and treatment"
SABCS 2021: Combined inhibition of CDK4/6 and AKT (LAR subtype)
SABCS 2024: Tumor heterogeneity and evolution
SABCS 2021: Genomic analysis of 733 HER2+ breast cancers identifies recurrent pathways alterations..
Genomic and transcriptomic landscape of HER2-low breast cancer
SABCS 2021: Novel immunotherapy approaches
SABCS Snippet - VIKTORIA-1 Phase 3 Topline Results - August 3, 2025
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored